These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 17293191)
1. Impact of gender on neointimal hyperplasia following coronary artery stenting. Kaneda H; Ako J; Kataoka T; Takahashi T; Terashima M; Waseda K; Miyazawa A; Hassan AH; Honda Y; Yock PG; Fitzgerald PJ Am J Cardiol; 2007 Feb; 99(4):491-3. PubMed ID: 17293191 [TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of neointimal distribution of in-stent restenosis in patients with diabetes mellitus. Kaneda H; Ako J; Kataoka T; Takahashi T; Terashima M; Waseda K; Miyazawa A; Hassan A; Honda Y; Yock PG; Fitzgerald PJ Am J Cardiol; 2006 Feb; 97(3):340-2. PubMed ID: 16442392 [TBL] [Abstract][Full Text] [Related]
3. Vascular response to sirolimus-eluting stents delivered with a nonaggressive implantation technique: comparison of intravascular ultrasound results from the multicenter, randomized E-SIRIUS, and SIRIUS trials. Hoffmann R; Guagliumi G; Musumeci G; Reimers B; Petronio AS; Disco C; Amoroso G; Moses JW; Fitzgerald PJ; Schofer J; Leon MB; Breithardt G Catheter Cardiovasc Interv; 2005 Dec; 66(4):499-506. PubMed ID: 16273564 [TBL] [Abstract][Full Text] [Related]
4. Small stent size and intimal hyperplasia contribute to restenosis: a volumetric intravascular ultrasound analysis. Dussaillant GR; Mintz GS; Pichard AD; Kent KM; Satler LF; Popma JJ; Wong SC; Leon MB J Am Coll Cardiol; 1995 Sep; 26(3):720-4. PubMed ID: 7642865 [TBL] [Abstract][Full Text] [Related]
5. Thiazolidinedione treatment attenuates diffuse neointimal hyperplasia in restenotic lesions after coronary stent implantation in type 2 diabetic patients: an intravascular ultrasound study. Takagi T; Yamamuro A; Tamita K; Katayama M; Morioka S J Cardiol; 2005 Apr; 45(4):139-47. PubMed ID: 15875535 [TBL] [Abstract][Full Text] [Related]
6. Nonuniform strut distribution correlates with more neointimal hyperplasia after sirolimus-eluting stent implantation. Takebayashi H; Mintz GS; Carlier SG; Kobayashi Y; Fujii K; Yasuda T; Costa RA; Moussa I; Dangas GD; Mehran R; Lansky AJ; Kreps E; Collins MB; Colombo A; Stone GW; Leon MB; Moses JW Circulation; 2004 Nov; 110(22):3430-4. PubMed ID: 15557367 [TBL] [Abstract][Full Text] [Related]
7. Revisiting late loss and neointimal volumetric measurements in a drug-eluting stent trial: analysis from the SPIRIT FIRST trial. Tsuchida K; García-García HM; Ong AT; Valgimigli M; Aoki J; Rademaker TA; Morel MA; van Es GA; Bruining N; Serruys PW Catheter Cardiovasc Interv; 2006 Feb; 67(2):188-97. PubMed ID: 16400664 [TBL] [Abstract][Full Text] [Related]
8. Neointimal progression and luminal narrowing in sirolimus-eluting stent treatment for bare metal in-stent restenosis: a quantitative intravascular ultrasound analysis. Sakurai R; Ako J; Hassan AH; Bonneau HN; Neumann FJ; Desmet W; Holmes DR; Yock PG; Fitzgerald PJ; Honda Y Am Heart J; 2007 Aug; 154(2):361-5. PubMed ID: 17643589 [TBL] [Abstract][Full Text] [Related]
9. Effect of plaque debulking before stent implantation on in-stent neointimal proliferation: a serial 3-dimensional intravascular ultrasound study. Takeda Y; Tsuchikane E; Kobayashi T; Terai K; Kobayashi Y; Nakagawa T; Sakurai M; Awata N; Kobayashi T Am Heart J; 2003 Jul; 146(1):175-82. PubMed ID: 12851628 [TBL] [Abstract][Full Text] [Related]
10. Pioglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with type 2 diabetes mellitus: an intravascular ultrasound scanning study. Takagi T; Yamamuro A; Tamita K; Yamabe K; Katayama M; Mizoguchi S; Ibuki M; Tani T; Tanabe K; Nagai K; Shiratori K; Morioka S; Yoshikawa J Am Heart J; 2003 Aug; 146(2):E5. PubMed ID: 12891212 [TBL] [Abstract][Full Text] [Related]
11. Impact of intravascular ultrasound lesion characteristics on neointimal hyperplasia following sirolimus-eluting stent implantation. Kaneda H; Koizumi T; Ako J; Terashima M; Morino Y; Honda Y; Yock PG; Leon MB; Moses JW; Fitzgerald PJ Am J Cardiol; 2005 Nov; 96(9):1237-41. PubMed ID: 16253589 [TBL] [Abstract][Full Text] [Related]
12. Reduction of neointimal hyperplasia after coronary stenting by pioglitazone in nondiabetic patients with metabolic syndrome. Katayama T; Ueba H; Tsuboi K; Kubo N; Yasu T; Kuroki M; Saito M; Momomura S; Kawakami M Am Heart J; 2007 May; 153(5):762.e1-7. PubMed ID: 17452150 [TBL] [Abstract][Full Text] [Related]
13. Influence of plaque calcium on neointimal hyperplasia following bare metal and drug-eluting stent implantation. Shimada Y; Kataoka T; Courtney BK; Morino Y; Bonneau HN; Yock PG; Grube E; Honda Y; Fitzgerald PJ Catheter Cardiovasc Interv; 2006 Jun; 67(6):866-9. PubMed ID: 16649232 [TBL] [Abstract][Full Text] [Related]
15. Relationship between neointimal regrowth and mechanism of acute lumen gain during the treatment of in-stent restenosis with or without supplementary intravascular radiation. Morino Y; Limpijankit T; Honda Y; Somrantin M; Waksman R; Bonneau HN; Yock PG; Mintz GS; Fitzgerald PJ Catheter Cardiovasc Interv; 2003 Feb; 58(2):162-7. PubMed ID: 12552537 [TBL] [Abstract][Full Text] [Related]
16. Volumetric intravascular ultrasound assessment of neointimal hyperplasia and nonuniform stent strut distribution in sirolimus-eluting stent restenosis. Sano K; Mintz GS; Carlier SG; Fujii K; Takebayashi H; Kimura M; Costa JR; Tanaka K; Costa RA; Lui J; Weisz G; Moussa I; Dangas GD; Mehran R; Lansky AJ; Kreps EM; Collins M; Stone GW; Moses JW; Leon MB Am J Cardiol; 2006 Dec; 98(12):1559-62. PubMed ID: 17145209 [TBL] [Abstract][Full Text] [Related]
18. Neointimal hyperplasia and late pathologic remodeling in a porcine coronary stent model. De Scheerder I ; Wang K; Zhou XR; Verbeken E; Ping QB; Yanming H; Jianhua H; Szilard M; Van de Werf F J Invasive Cardiol; 1999 Jan; 11(1):9-12. PubMed ID: 10745430 [TBL] [Abstract][Full Text] [Related]